Corient Private Wealth
GMED icon

Corient Private Wealth’s Globus Medical GMED Stock Holding History

Corient Private Wealth’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
216,853
+32,343
+18% +$2.75M 0.02% 467
2026
Q1 		$15.8M Buy
184,510
+133,138
+259% +$11.9M 0.02% 461
2025
Q4 		$4.49M Buy
51,372
+3,390
+7% +$257K 0.01% 810
2025
Q3 		$2.75M Buy
47,982
+1,252
+3% +$72.1K ﹤0.01% 935
2025
Q2 		$2.76M Buy
46,730
+310
+0.7% +$20K ﹤0.01% 904
2025
Q1 		$3.4M Sell
46,420
-18,924
-29% -$1.56M 0.01% 802
2024
Q4 		$5.4M Sell
65,344
-7,985
-11% -$630K 0.01% 674
2024
Q3 		$5.25M Sell
73,329
-3,139
-4% -$222K 0.01% 736
2024
Q2 		$5.24M Buy
76,468
+244
+0.3% +$14.6K 0.01% 698
2024
Q1 		$4.09M Buy
76,224
+2,204
+3% +$118K 0.01% 765
2023
Q4 		$3.94M Buy
74,020
+2,038
+3% +$99.3K 0.01% 767
2023
Q3 		$3.57M Buy
71,982
+1,393
+2% +$77.9K 0.01% 723
2023
Q2 		$4.2M Buy
70,589
+7,219
+11% +$411K 0.01% 678
2023
Q1 		$3.59M Buy
63,370
+175
+0.3% +$11.2K 0.01% 679
2022
Q4 		$4.69M Buy
+63,195
New +$4.3M 0.02% 520

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Corient Private Wealth's GMED Position: Q2 2026 in Review

Corient Private Wealth increased its Globus Medical (GMED) stake by 18% in Q2 2026, buying an estimated $2.75M and bringing the position to 216,853 shares worth $17.1M. The position accounts for 0.02% of the portfolio, ranked #467.

Corient Private Wealth first reported a position in GMED in Q4 2022 and has held it in 15 quarters since. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Corient Private Wealth held 216,853 shares of Globus Medical worth $17.1M as of Q2 2026.
  • Corient Private Wealth bought 32,343 Globus Medical shares in Q2 2026, an estimated $2.75M.
  • Globus Medical made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #467 holding.
  • Corient Private Wealth first reported a position in Globus Medical in Q4 2022 and has held it in 15 quarters since.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.